November 15-19, 2016 marked the 44th Annual VEITHsymposium, a 5-day conference where vascular specialists gathered to learn about innovations in vascular disease treatment. Dr. Matthew Eagleton, Chair of the Centerline Biomedical Scientific Advisory Board, spoke at the event, presenting IOPS and the opportunities it uncovers, simplifying vascular surgery.
Eagleton explained that IOPS, with its 3-D vascular imagery and electromagnetic tracking features, gives operators clear, ideal views of vasculature that are “superior to standard 2-D fluoroscopy.”
An important takeaway from Eagleton’s presentation is that although the initial testing of IOPS was aortic, the device “is not limited to the aorta.” IOPS can be adapted for use in other areas of vasculature, where minimally-invasive procedures are preferable, including the peripheral arteries, lungs and nervous system.
Minimally-invasive surgery is a hot topic right now, and for good reason. These repairs provide faster recovery, cost less and offer a better outcome. In the long run, we hope to facilitate a variety of minimally-invasive surgeries to allow patients and caregivers the best possible quality of life.
Read more about Dr. Eagleton’s presentation at VEITHsymposium here. For more information on the future of IOPS, check out this interview with inventor and Chief Technology Officer, Vikash Goel.